# Efficacy of Intralesional PRP +/- Topical Silymarin in the Treatment of Melasma

> **NCT05626881** · NA · UNKNOWN · sponsor: **Sohag University** · enrollment: 60 (estimated)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** PRP
- **DRUG:** sylimarin cream

## Key facts

- **NCT ID:** NCT05626881
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05626881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05626881, "Efficacy of Intralesional PRP +/- Topical Silymarin in the Treatment of Melasma". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT05626881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
